The European Union (EU), which was in courtroom with AstraZeneca due to the delay within the provide of vaccines, is experiencing the identical downside this time with a distinct firm.
There will be a delay within the delivery of vaccines developed by Johnson & Johnson towards coronavirus.
55 MILLION DOSE WILL BE DELAYED
Stefan de Keersmaecker, one of the spokespersons of the EU Fee, reminded that the contents of the coronavirus vaccine have been combined with the contents of one other vaccine at Johnson & Johnson’s manufacturing amenities within the USA final week.
Emphasizing that the corporate’s vaccines produced on this facility have been quickly not distributed within the EU for precautionary functions, Keersmaecker stated, “In consequence, we anticipate that the corporate will not be ready to ship the 55 million doses it wants to present by the top of the second quarter.” stated.
200 MILLION DOSE AGREEMENT
The EU has an settlement with Johnson & Johnson to buy 200 million doses of the vaccine. 55 million doses of the single-dose vaccines have been supposed to be delivered by the top of the second quarter.
It was acknowledged that the quantity of vaccines that might not be delivered due to the disruption in manufacturing was 17 million doses. It’s acknowledged that the corporate has despatched 12 million doses of vaccine to the EU thus far.
EU-APPROVED VACCINES
To this point, the EU has authorised vaccines from BioNTech-Pfizer, AstraZeneca and Moderna, aside from Johnson and Johnson.
Due to the issues encountered within the delivery of AstraZeneca vaccines prior to now, AB centered on BioNTech-Pfizer vaccine.
#Johnson #Johnsons #delivery #coronavirus #vaccine #delayed
Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.
https://m.ensonhaber.com/dunya/johnson-johnsonin-abye-koronavirus-asisi-teslimati-gecikecek
